1. Home
  2. SCYX vs CMTL Comparison

SCYX vs CMTL Comparison

Compare SCYX & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCYX
  • CMTL
  • Stock Information
  • Founded
  • SCYX 1999
  • CMTL 1967
  • Country
  • SCYX United States
  • CMTL United States
  • Employees
  • SCYX N/A
  • CMTL N/A
  • Industry
  • SCYX Biotechnology: Pharmaceutical Preparations
  • CMTL Radio And Television Broadcasting And Communications Equipment
  • Sector
  • SCYX Health Care
  • CMTL Technology
  • Exchange
  • SCYX Nasdaq
  • CMTL Nasdaq
  • Market Cap
  • SCYX 50.3M
  • CMTL 107.5M
  • IPO Year
  • SCYX 2014
  • CMTL N/A
  • Fundamental
  • Price
  • SCYX $1.02
  • CMTL $4.37
  • Analyst Decision
  • SCYX Buy
  • CMTL Strong Buy
  • Analyst Count
  • SCYX 1
  • CMTL 1
  • Target Price
  • SCYX N/A
  • CMTL $9.25
  • AVG Volume (30 Days)
  • SCYX 210.1K
  • CMTL 507.6K
  • Earning Date
  • SCYX 11-06-2024
  • CMTL 12-31-2024
  • Dividend Yield
  • SCYX N/A
  • CMTL N/A
  • EPS Growth
  • SCYX N/A
  • CMTL N/A
  • EPS
  • SCYX N/A
  • CMTL N/A
  • Revenue
  • SCYX $8,566,000.00
  • CMTL $540,403,000.00
  • Revenue This Year
  • SCYX N/A
  • CMTL $0.96
  • Revenue Next Year
  • SCYX $405.82
  • CMTL $10.66
  • P/E Ratio
  • SCYX N/A
  • CMTL N/A
  • Revenue Growth
  • SCYX N/A
  • CMTL N/A
  • 52 Week Low
  • SCYX $0.90
  • CMTL $1.53
  • 52 Week High
  • SCYX $3.07
  • CMTL $8.71
  • Technical
  • Relative Strength Index (RSI)
  • SCYX 34.82
  • CMTL 69.58
  • Support Level
  • SCYX $0.90
  • CMTL $3.69
  • Resistance Level
  • SCYX $1.04
  • CMTL $4.71
  • Average True Range (ATR)
  • SCYX 0.07
  • CMTL 0.45
  • MACD
  • SCYX -0.01
  • CMTL 0.09
  • Stochastic Oscillator
  • SCYX 34.10
  • CMTL 82.83

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against a broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of modern communications solution incorporated in USA. The company is engaged in designing, developing, producing and marketing products, systems, and services for communications solutions. It is engaged in two business segments, Satellite and Space Communications and Terrestrial and Wireless Networks. It's Space and satellite is USA based providers of modems and high-power amplifiers, a market leader in troposcatter technologies, and serves some of the world's defense contractors and allied foreign governments. Terrestrial and Wireless Networks segment is a provider of next generation 911 infrastructure and solutions for state and local governments and carriers. Majority of sales are generated from Satellite and Space Communications segment.

Share on Social Networks: